siRNA treatment decreases triglycerides in individuals along with rare disorder
.RESEARCH FEATURE.19 September 2024.
Plozasiran reduced triglyceride degrees through 80% and also decreased the danger of pancreatitis in clients along with persistent chylomicronemia, along with or even without a hereditary diagnosis.